Learn from regulatory experts as they discuss regulatory insights throughout every stage of your product lifecycle.
- First steps to building a regulatory roadmap
- Considerations for Investigational New Drug applications (INDs), New Drug Applications (NDAs), and Biologics License Applications (BLAs)
- Impact of a robust regulatory strategy
- Cardinal Health Regulatory Sciences expertise
A history of success
Cardinal Health Regulatory Sciences supports biopharmaceutical, cell and gene therapies (CGTs), and medical device programs from the early proof of concept through to regulatory approval and product launch. Our team of more than 150 sciences deliver proven regulatory expertise to accelerate approvals and optimize the product life cycle.
- We have supported over 1000 regulatory submissions worldwide
- In the last five years, we have supported more than 300 NDAs, BLAs, and ANDAs and more than 90 INDs
Our services help your critical therapies become market-ready as soon as possible — so patients get access to what they need, when they need it. Our curated solutions can be customized and will be delivered by a reliable and efficient team that acts as an extension of your own.